Advertisement
Screener

SERA PROGNOSTICS, INC. (SERA) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

SERA PROGNOSTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where SERA PROGNOSTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $25.62M went out.
  • Fiscal year ended 2025-12-31: from investing, $28.50M went out.
  • Fiscal year ended 2025-12-31: from financing, $54.03M came in.
  • Fiscal year ended 2025-12-31: change in cash, $99.00K went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$25.62M-$28.50M$53.61M-$99.00K
2024-12-31-$14.19M$11.74M$2.90M$163.00K
2023-12-31-$27.19M$438.00K$1.09M-$26.00M
2022-12-31-$34.61M$5.55M$0.00$308.00K-$29.05M
2021-12-31-$31.64M-$82.56M-$3.10M$0.00$592.00K$162.10M*$45.40M
2020-12-31-$16.87M-$149.00K$0.00$1.05M$176.00K$7.93M*-$7.86M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$6.31M*$6.39M*$0.00*
2026-03-31-$8.77M$8.98M$0.00$231.00K
2025-12-31-$6.12M*$5.89M*$0.00*
2025-09-30-$6.48M*$5.17M*$0.00*
2025-06-30-$5.47M*$5.24M*$0.00*
2025-03-31-$7.55M-$44.80M$53.61M$1.19M
2024-12-31-$6.26M*$7.38M*$254.00K*
2024-09-30-$7.00M*$4.90M*$0.00*
2024-06-30-$5.93M*$5.15M*$0.00*$1.20M*
2024-03-31$4.99M-$5.69M$0.00$1.05M*$359.00K
2023-12-31-$6.76M*$374.00K*$669.00K*
2023-09-30-$7.59M*-$15.16M*$244.00K*
2023-06-30-$7.95M*$12.91M*$178.00K*
2023-03-31-$4.88M$2.32M$4.00K-$2.68M
2022-12-31-$7.24M*-$1.58M*$0.00*$1.00K*
2022-09-30-$8.78M*-$6.30M*$0.00*$93.00K*
2022-06-30-$9.04M*-$1.21M*$0.00*$125.00K*
2022-03-31-$9.56M$14.63M$0.00$89.00K$5.15M
2021-12-31-$9.15M*-$14.43M*$0.00*$0.00*$55.00K*
2021-09-30-$9.30M*-$68.00M*$0.00*$0.00*$273.00K*$68.65M*
2021-06-30-$6.24M*-$85.00K*$0.00*$35.00K*$37.12M*
2021-03-31-$6.95M-$41.00K-$3.10M$229.00K$56.34M*$46.48M
2020-12-31-$4.18M*-$44.00K*$0.00*$0.00*$97.00K*-$1.02M*
2020-09-30-$3.92M*-$83.00K*$0.00*$0.00*$78.00K*-$1.02M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45